Heart Arrest Clinical Trial
— SELECTOfficial title:
Early Cessation of Sedation and TTM in Patients With a Favourable EEG After Cardiac Arrest: a Feasibility and Safety Study
The objective of this study is to estimate the feasibility and safety of early weaning from ICU treatment in patients after cardiac arrest and an early (< 12 h) favourable EEG pattern (indicating no or mild postanoxic encephalopathy).
Status | Recruiting |
Enrollment | 40 |
Est. completion date | October 2026 |
Est. primary completion date | October 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients after cardiac arrest admitted to the ICU for treatment with sedation, TTM and mechanical ventilation. - Age 18 years or older. - Continuous EEG measurement started within 12 hours after cardiac arrest. - Favourable EEG pattern within 12 hours after arrest, defined as a continuous background pattern (NVN, 2019; Ruijter et al., 2019). - Possibility to stop sedative treatment within three hours after identification of a favourable EEG pattern. - Written informed consent (deferred). Exclusion Criteria: - A known history of another medical condition with limited life expectancy (<6 months). - Any progressive brain illness, such as a brain tumour or neurodegenerative disease. - Pre-admission Glasgow Outcome Scale Extended score of 4 or lower. - Reason other than neurological condition to continue sedation and/or ventilation. - Follow-up impossible due to logistic reasons. |
Country | Name | City | State |
---|---|---|---|
Netherlands | Rijnstate hospital | Arnhem | Gelderland |
Netherlands | Medisch Spectrum Twente | Enschede | Overijssel |
Lead Sponsor | Collaborator |
---|---|
Medisch Spectrum Twente | Rijnstate Hospital, University of Twente |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mechanical ventilation time in hours | During the complete ICU admission (from admission to the ICU until discharge from the ICU, up to 30 days). | ||
Secondary | Length of ICU stay | During the complete ICU admission (from admission to the ICU until discharge from the ICU, up to 30 days). | ||
Secondary | Total sedation time | During the complete ICU admission (from admission to the ICU until discharge from the ICU, up to 30 days). | ||
Secondary | Need for re-intubation | During the complete ICU admission (from admission to the ICU until discharge from the ICU, up to 30 days). | ||
Secondary | Need for restarting sedation | During the complete ICU admission (from admission to the ICU until discharge from the ICU, up to 30 days). | ||
Secondary | Number of serious adverse events (SAEs) | at 3 and 6 months | ||
Secondary | Mortality | at 30 days, 3 months and 6 months | ||
Secondary | Complications during intensive care admission | Number of pneumonia, sepsis (according to sepsis 3 criteria), bleeding (any cause), cardiac arrhythmia (any associated with hemodynamic compromise), new cardiac arrest and thrombopenia | During the complete ICU admission (from admission to the ICU until discharge from the ICU, up to 30 days). | |
Secondary | Neurological outcome measured at the Extended Glasgow Outcome Scale (GOSE) | The CPC ranges from 1 to 8, with higher scores meaning better neurological outcome. | at 3 and 6 months | |
Secondary | Neurological outcome measured at the Cerebral Performance Category (CPC) | The CPC ranges from 1 to 5, with higher scores meaning worse neurological outcome. | at 3 and 6 months | |
Secondary | Cognitive functioning | Montreal Cognitive Assessment (MOCA) score via videoconference. The MOCA ranges from 0 to 30, with higher scores meaning better cognitive functioning. | at 3 and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04078815 -
End-of-life Practices in 2019 vs. 2014
|
||
Completed |
NCT02816385 -
Study of Myocardial Contractility After Cardiac Surgery Under an Anterograde or Retrograde Cardioplegia
|
N/A | |
Completed |
NCT02486211 -
Amantadine to Speed Awakening After Cardiac Arrest
|
Phase 2 | |
Recruiting |
NCT02326506 -
Evaluation of Drainable Volume Measurements During VA-ELS
|
N/A | |
Completed |
NCT00139542 -
AED Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named "One Shock Per Minute"
|
Phase 3 | |
Completed |
NCT00004560 -
Public Access Defibrillation (PAD) Community Trial
|
Phase 3 | |
Completed |
NCT00000502 -
Evaluation of SC-V Versus Conventional CPR
|
Phase 3 | |
Completed |
NCT03640949 -
Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest
|
Phase 2/Phase 3 | |
Completed |
NCT03310450 -
Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels
|
||
Completed |
NCT02733146 -
Histones and Free-plasma DNA After Cardiac Arrest
|
N/A | |
Withdrawn |
NCT01082991 -
Patient Acuity Rating: a Tool to Prevent In-Hospital Cardiac Arrest
|
Phase 0 | |
Terminated |
NCT00189423 -
ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest
|
N/A | |
Completed |
NCT00172354 -
Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest
|
N/A | |
Completed |
NCT02858583 -
SI + CC Versus 3:1 C:V Ratio During Neonatal CPR
|
N/A | |
Completed |
NCT03664557 -
Feasibility of REBOA in Refractory Cardiac Arrest
|
N/A | |
Completed |
NCT01968148 -
Mechanisms of Ultra-acute Hyperglycemia After Successful Resuscitation From Out-of-hospital Cardiac Arrest
|
N/A | |
Completed |
NCT00392639 -
Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA Study)
|
Phase 4 | |
Recruiting |
NCT06081283 -
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT05321459 -
Predictive Outcome in Comatose Patients
|
||
Completed |
NCT02780050 -
Influence of Core Muscles Activation Using Physical Fitness on the Performance of Chest Compression
|
N/A |